Otto Ettala
otolet@utu.fi |
- Detection of prostate cancer bone metastases with fast whole-body Tc-99m-HMDP SPECT/CT using a general-purpose CZT system (2022)
- EJNMMI Physics
- Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer (2022)
- Journal of Magnetic Resonance Imaging
- Erikoissairaanhoidon työnjako harvoin tehtävissä ja vaativissa toimenpiteissä - hoidon laadun ja vaikuttavuuden arvioiminen urologisissa syöpätaudeissa (2022)
- Duodecim
- Incidence of and mortality from Bacille Calmette-Guerin (BCG) infections after BCG instillation therapy (2022)
- BJU International
- Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)
- Cancers
- Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)
- BMJ Open
- Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study (2022)
- World Journal of Urology
- Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score (2022)
- European Urology
- Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol (2022)
- BMJ Open
- The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator (2022)
- European Urology Open Science
- The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)
- Human Molecular Genetics
- Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study (2022)
- Cancer Biotherapy and Radiopharmaceuticals
- Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth (2021)
- International Journal of Radiation Oncology - Biology - Physics
- A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE) (2021)
- European Urology Oncology
- A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma (2021)
- Scientific Reports
- Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study (2021)
- npj Precision Oncology
- Does every Clavien-Dindo complication matter? A national multi-center study in kidney cancer surgery (2021)
- Scandinavian Journal of Urology
- Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy (2021)
- BMC Urology
- How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database (2021)
- Acta Radiologica Open
- Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancer (2021)
- European Journal of Nuclear Medicine and Molecular Imaging